ArticleLipids in health and disease2014

Inhibiting CB1 receptors improves lipogenesis in an in vitro non-alcoholic fatty liver disease model.

Dongmei Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.